Case Details
- Citation: [2023] SGHC 182
- Title: Public Prosecutor v Affandi bin Mohamed Hassan
- Court: High Court of the Republic of Singapore (General Division)
- Criminal Case No: Criminal Case No 12 of 2023
- Date of Decision: 30 June 2023
- Judges: See Kee Oon J
- Hearing Dates: 23–24, 28–29, 31 March, 13 April 2023
- Plaintiff/Applicant: Public Prosecutor
- Defendant/Respondent: Affandi bin Mohamed Hassan
- Legal Area: Criminal Law — Statutory offences
- Statutory Provisions Referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”); Criminal Procedure Code 2010 (2020 Rev Ed) (“CPC”)
- Charge: s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act for possession of a controlled drug for the purpose of trafficking
- Controlled Drug(s): Diamorphine (heroin)
- Quantity: 2,752.64g of granular/powdery substance containing not less than 24.64g of diamorphine
- Drug Sets Analysed: “A”, “B” and “D” drugs (with “C” and “E” drugs found but not charged)
- Place of Recovery: Block 305 Serangoon Avenue 2, #04-88, Singapore (“the flat”)
- Arrest: 10 December 2020 by CNB officers
- Key Evidence: DNA findings; HSA certificates; POLCAM footage; statements recorded under CPC; psychiatric assessment (IMH Report)
- Outcome at Trial: Convicted; sentenced to the mandatory death sentence
- Judgment Length: 38 pages, 9,899 words
- Cases Cited: [2015] SGCA 33; [2023] SGHC 182
Summary
In Public Prosecutor v Affandi bin Mohamed Hassan ([2023] SGHC 182), the High Court (See Kee Oon J) convicted the accused of an offence under s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act (“MDA”) for possessing diamorphine for the purpose of trafficking. The charge concerned a large quantity of granular/powdery substance which, upon analysis, was found to contain not less than 24.64g of diamorphine (heroin). The drugs were recovered from the accused’s residence, a flat at Block 305 Serangoon Avenue 2, where the accused was arrested by the Central Narcotics Bureau (“CNB”).
The prosecution’s case turned on two main factual disputes raised by the defence. First, the accused admitted an intention to traffic the “A” and “D” drugs but denied that he intended to traffic the smaller “B” drugs, claiming they were for personal consumption. Second, for the “D” drugs, the accused attempted to characterise himself as a mere courier who received the drugs on instructions from others, rather than as a person who was actively involved in trafficking. The court rejected both defences, finding that the prosecution proved beyond a reasonable doubt that the accused possessed the “B” drugs for trafficking and that he was not a mere courier in respect of the “D” drugs.
What Were the Facts of This Case?
The accused, Affandi bin Mohamed Hassan, was arrested on 10 December 2020 at the flat where he resided. CNB officers acted on information relating to drug activities. The flat belonged to a brother of the accused’s friend, “Talib”, who lived there with his Filipino wife. The accused was previously convicted for various offences, including drug offences, and had been released from prison in 2018 after serving a sentence under the LT-2 regime as a repeat offender for drug consumption. After his release, he worked as a laundry operator until mid-2019 and then remained unemployed until his arrest.
At trial, the parties tendered a 51-page Statement of Agreed Facts (“SOAF”) pursuant to s 267(1) of the Criminal Procedure Code 2010 (2020 Rev Ed) (“CPC”). There was substantial agreement on the prosecution’s evidence, including the chain of custody and DNA analysis conducted by the Health Sciences Authority (“HSA”). The accused did not dispute that he knew the drugs contained diamorphine and that he was in possession of the drugs recovered from the flat. The drugs were recovered from different locations within the flat, and the court treated the charged drugs as comprising three sets: “A”, “B” and “D”.
The “A” drugs were 61 packets of diamorphine seized from under the bed in the bedroom beside the kitchen. The HSA analysis determined that the “A” drugs contained not less than 6.96g of diamorphine in total. The “B” drugs comprised four packets and two straws of diamorphine found in a box seized from the bedside table in the bedroom. The HSA analysis determined that the “B” drugs contained not less than 0.24g of diamorphine in total. The “D” drugs comprised three bundles wrapped in black tape seized from the dining table in the living room. These bundles were marked “D1A”, “D1B” and “D1C1”, containing a total of not less than 17.44g of diamorphine.
In addition to the charged drugs, other drugs were found in the flat, referred to as “C” and “E” drugs, but these were not the subject matter of the charge. The flat also contained drug consumption paraphernalia, including glass utensils, improvised smoking utensils, lighters, aluminium foil, cotton buds, stained spoons, syringes and straws. Trafficking-related paraphernalia was also seized, including empty plastic packets, digital weighing scales and masking tape. The accused’s DNA was found on numerous exhibits related to the “A”, “B” and “D” drugs. However, for the “D” drugs specifically, his DNA was not detected on the exterior or interior of the black-taped bundles, though his DNA was detected on other related items. The court also considered HSA urine analysis: the accused’s urine contained monoacetylmorphine (a metabolite of diamorphine) and other drug metabolites, supporting that he had been exposed to drugs.
What Were the Key Legal Issues?
The first legal issue was whether the prosecution proved that the accused possessed the “B” drugs for the purpose of trafficking, given the defence position that the “B” drugs were intended for personal consumption. Although the accused admitted an intention to traffic the “A” and “D” drugs, he disputed the trafficking purpose in relation to the “B” drugs. This required the court to evaluate whether the totality of circumstances supported trafficking rather than consumption, even though the quantity of “B” drugs was smaller than “A” and “D”.
The second legal issue concerned the “D” drugs. The accused argued that he was a courier, implying that he merely received the drugs from others and did not himself participate in trafficking in the substantive sense required by the statutory framework. The court therefore had to determine whether the accused’s role was consistent with being a mere courier, or whether the evidence showed he was more than a passive messenger and was sufficiently involved in trafficking such that the trafficking purpose could be attributed to him.
Underlying both issues was the broader question of how the court should assess credibility and intent in a statutory drug trafficking case, particularly where the accused’s statements to investigators were alleged to be inconsistent and where there were contextual indicators such as paraphernalia, packaging, and the accused’s knowledge and possession of the drugs within his residence.
How Did the Court Analyse the Issues?
The court approached the case by first grounding itself in the agreed and undisputed facts, particularly the accused’s possession of the drugs and his knowledge that they contained diamorphine. The statutory offence under s 5(1)(a) read with s 5(2) of the MDA focuses on possession “for the purpose of trafficking”. While possession and knowledge were not seriously disputed, the trafficking purpose required careful inference from the surrounding circumstances. The court also noted that the chain of custody and DNA analysis were not disputed, and that the statements recorded from the accused were admitted without challenge as to voluntariness.
On the “B” drugs, the court examined whether the defence’s claim of personal consumption was credible in light of the physical context and the accused’s overall conduct. The “B” drugs were found in a box in the bedroom bedside table area, within the same residence where the accused possessed large quantities of diamorphine in the “A” and “D” sets. The presence of trafficking-related paraphernalia in the flat, including weighing scales and masking tape, supported an inference that the drugs were being handled in a manner consistent with distribution rather than mere personal use. Further, the accused’s DNA was found on numerous exhibits related to the charged drugs, and the court treated this as consistent with active involvement in the drug-related activities within the flat.
Although the “B” drugs were smaller in quantity, the court did not treat quantity alone as determinative. Instead, it assessed whether the accused’s explanation could reasonably account for the location of the “B” drugs, their packaging form (packets and straws), and the broader trafficking ecosystem in the flat. The court also considered the accused’s prior drug-related conviction and his history of drug consumption, including the IMH Report indicating likely opiate use disorder at the time of the offence. However, the court’s reasoning reflected the principle that drug addiction or consumption does not negate trafficking purpose where the evidence indicates distribution intent. The court ultimately found that the prosecution had proven beyond a reasonable doubt that the accused intended to traffic the “B” drugs as well.
For the “D” drugs, the court analysed the accused’s “courier” defence through the lens of credibility, consistency, and objective indicators. The prosecution highlighted that the accused gave inconsistent accounts in his investigative statements regarding how he came to receive the “D” drugs from “Bob”, and whether he would be paid $500 by “Ah Kwang” or was merely doing a favour for “Salim Babu” (also known as “Salim”). The accused also gave shifting accounts about the intended recipients of the “D” drugs, involving “Aboy Tamling” (also known as “Hassan Pekboon” or “Pekboon”), Salim and himself. These inconsistencies extended to how many “stones” were meant for each person and whether the remaining portion would be split between Salim and the accused.
The court treated these inconsistencies as undermining the courier narrative. A courier defence typically requires the court to accept that the accused’s role was limited to receiving and passing drugs without substantive involvement in trafficking. Here, the court found that the accused’s accounts were not only inconsistent but also changed in material respects. The court also considered the alleged phone call evidence and the lack of incoming calls from foreign numbers during relevant periods, as well as alleged payments from Salim and “Pekboon” and the quantity of drugs involved. While the judgment extract provided does not reproduce all the evidential details, it is clear from the structure of the decision that the court evaluated these contextual factors as part of a holistic assessment of whether the accused was acting as a mere intermediary.
Importantly, the court also considered objective evidence from POLCAM footage. The court had access to footage from lift lobby “B” and a stairwell between the ground floor and the second floor of Block 305 for specified dates and times, as well as footage for 9 December 2020. The court’s reasoning indicates that the footage was used to test the accused’s narrative about movements and interactions, including whether he was present at locations consistent with his account of receiving the drugs. The court’s evaluation of the “courier” defence therefore combined (i) the accused’s inconsistent statements, (ii) the objective camera evidence, and (iii) the physical and forensic context in the flat.
Finally, the court addressed the accused’s DNA profile in relation to the “D” bundles. While the accused’s DNA was not detected on the exterior or interior of the black-taped bundles “D1A”, “D1B” and “D1C1”, the court did not treat this as conclusive of non-involvement. The court considered that DNA absence on the bundles themselves could be consistent with packaging practices or handling by others, particularly where the accused’s DNA was detected on numerous other related exhibits. The court’s reasoning reflects a common approach in drug cases: forensic evidence is assessed in context, and the absence of DNA on particular items does not automatically negate possession or trafficking purpose where other evidence supports involvement.
What Was the Outcome?
At the conclusion of the trial, the court was satisfied that the prosecution proved the charge beyond a reasonable doubt. The accused was convicted under s 5(1)(a) read with s 5(2) of the MDA for possessing diamorphine for the purpose of trafficking. The court rejected the defence that the “B” drugs were for personal consumption and rejected the “courier” defence in relation to the “D” drugs.
Following conviction, the accused was sentenced to the mandatory death sentence. The court delivered brief oral grounds at the time of conviction and then issued full written grounds setting out its reasoning in detail.
Why Does This Case Matter?
This decision is significant for practitioners because it illustrates how the High Court evaluates trafficking purpose where the accused attempts to compartmentalise drug sets within the same residence. Even where the accused admits trafficking intent for some quantities (“A” and “D”), the court will scrutinise whether smaller quantities (“B”) are truly for consumption, especially where the physical layout, packaging, and presence of trafficking paraphernalia point towards distribution. The case therefore reinforces that trafficking purpose is inferred from the totality of circumstances rather than from quantity alone.
It is also useful for understanding the limits of a courier defence. The court’s reasoning shows that inconsistent investigative accounts about recipients, payment, and the circumstances of receipt can be fatal to the credibility of the courier narrative. In addition, the court’s engagement with objective evidence such as POLCAM footage demonstrates that courts will test an accused’s story against contemporaneous records and contextual indicators, not merely against the accused’s assertions.
Finally, the case highlights that evidence of drug use disorder or drug metabolites in urine does not automatically negate trafficking intent. While such evidence may provide context for the accused’s drug exposure, it does not displace the statutory requirement that the prosecution prove possession for the purpose of trafficking. For lawyers, the case is a reminder to focus defence submissions on coherent, consistent explanations that can withstand both forensic and contextual scrutiny.
Legislation Referenced
- Criminal Procedure Code 2010 (2020 Rev Ed), s 267(1)
- Criminal Procedure Code 2010 (2020 Rev Ed), s 22 (statements recorded under s 22)
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 5(1)(a)
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 5(2)
Cases Cited
- [2015] SGCA 33
- [2023] SGHC 182
Source Documents
This article analyses [2023] SGHC 182 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.